Plasmodium vivax and the Duffy antigen: a paradigm revisited (Q37775259)

23 August 2017

title

Plasmodium vivax and the Duffy antigen: a paradigm revisited (English)

1 reference

23 August 2017

0 references

2

1 reference

23 August 2017

O Mercereau-Puijalon

1

1 reference

23 August 2017

publication date

23 July 2010

1 reference

Transfusion Clinique et Biologique

23 August 2017

published in

1 reference

23 August 2017

volume

17

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

176-183

1 reference

A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

7 January 2021

A New Human Blood Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Identification of an erythrocyte component carrying the Duffy blood group Fya antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Chapter 9 the duffy antigen receptor for chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Neglect of Plasmodium vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium vivax: who cares?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Vivax malaria: neglected and not benign

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Resistance to therapies for infection by Plasmodium vivax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

A trial of combination antimalarial therapies in children from Papua New Guinea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Malaria in Brazil: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Mapping the global extent of malaria in 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Malaria diagnosis and hospitalization trends, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Vivax malaria: a major cause of morbidity in early infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The pathophysiology of vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Experimental testing of the immunity of Negroes to Plasmodium vivax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The Resistance Factor to Plasmodium vivax in Blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Erythrocyte Receptors for (Plasmodium Knowlesi) Malaria: Duffy Blood Group Determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Comparative genomics of the neglected human malaria parasite Plasmodium vivax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Targeting the Plasmodium vivax Duffy-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Pacific vivax malaria in the American Negro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

The origin and age of Plasmodium vivax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

alpha+-Thalassemia protects children against disease caused by other infections as well as malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

Duffy blood types and vivax malaria in Ethiopia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2010.06.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRACLI.2010.06.005

1 reference

release_j3sdpnztgnbkjj7kc6uvgw2zyi

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j3sdpnztgnbkjj7kc6uvgw2zyi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference